Macrovascular Disease
Showing 26 - 50 of >10,000
Fibroid Uterus Trial in Amsterdam (microvascular flow imaging)
Completed
- Fibroid Uterus
- microvascular flow imaging
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC
Dec 7, 2022
Metabolic Liver Diseases in Type 1 Diabetes Mellitus
Recruiting
- Non-alcoholic Fatty Liver Disease
- +3 more
-
Vilafranca Del Penedès, Barcelona, Spain
- +1 more
Sep 22, 2021
Diabetes, Type 2, Diabetic Angiopathies Trial (Heart-Protecting Musk Pill, Valsartan Capsules, Calcium Dobesilate Capsules)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Diabetic Angiopathies
- Heart-Protecting Musk Pill
- +2 more
- (no location specified)
Dec 7, 2021
Peripheral Arterial Disease, Diagnosis, Diabetic Foot Trial (Maximal Systolic Acceleration)
Not yet recruiting
- Peripheral Arterial Disease
- +2 more
- Maximal Systolic Acceleration
- (no location specified)
Dec 2, 2022
Renal Insufficiency, Chronic Trial in Richmond (Whole-body Passive Heat Therapy (HT), Thermoneutral Control (CON))
Recruiting
- Renal Insufficiency, Chronic
- Whole-body Passive Heat Therapy (HT)
- Thermoneutral Control (CON)
-
Richmond, VirginiaVirginia Commonwealth University
Jun 20, 2023
The Diabetes Prevention Program Outcomes Study AD/ADRD Project
Enrolling by invitation
- Diabetes
- +4 more
-
Phoenix, Arizona
- +26 more
Jan 19, 2023
Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab)
Active, not recruiting
- Carcinoma, Hepatocellular
-
Los Angeles, California
- +138 more
Aug 22, 2022
COPD, Emphysema, Emphysema or COPD Trial (dual anti-platelet therapy, Placebo)
Not yet recruiting
- COPD
- +2 more
- dual anti-platelet therapy
- Placebo
- (no location specified)
Oct 9, 2022
Microangiopathy, Diabetic, Polyphenol, Optical Tomography Trial in Guildford (Cocoa flavanol, Placebo)
Completed
- Microangiopathy, Diabetic
- +5 more
- Cocoa flavanol
- Placebo
-
Guildford, United KingdomUniversity of Surrey
Jul 4, 2022
HCC With Portal Vein Tumor Thrombosis on Basis of Risk Scoring
Completed
- Hepatocellular Carcinoma
- +2 more
-
Daegu, DalSeo-gu, Korea, Republic ofKeimyung university Dongsan Medical Center
Aug 16, 2023
Diabetes Type 2 in Obese Trial in Sanliurfa (REIKI)
Recruiting
- Diabetes Mellitus Type 2 in Obese
- REİKİ
-
Şanlıurfa, Turkey
- +1 more
Jul 4, 2023
Severe COVID-19 Pneumonia Trial in Créteil (Tinzaparin, Low dose prophylactic anticoagulation, Tinzaparin, High dose
Completed
- Severe COVID-19 Pneumonia
- Tinzaparin, Low dose prophylactic anticoagulation
- +2 more
-
Créteil, FranceHenri Mondor Hospital
Sep 5, 2022
Atherosclerosis of Artery, Peripheral Artery Disease, Diabetes Trial in Changsha, Jinan (N-acetylcysteine, Placebo)
Withdrawn
- Atherosclerosis of Artery
- +4 more
- N-acetylcysteine
- Placebo
-
Changsha, Hunan, China
- +1 more
Jun 9, 2023
Qataris With Type 2 Diabetes
Completed
- Type 2 Diabetes
-
Doha, QatarHamad Medical Corporation
Jan 26, 2022
Cardiovascular Health, Cardiovascular Risk Factor Trial in Newark (Potassium chloride supplement, Placebo)
Recruiting
- Cardiovascular Health
- Cardiovascular Risk Factor
- Potassium chloride supplement
- Placebo
-
Newark, DelawareTower at STAR
May 30, 2023
JARVISDHL Screening Tools
Not yet recruiting
- Coronary Artery Disease
- Ocular Imaging
- Questionnaires
-
Singapore, SingaporeNational Heart Centre Singapore
Nov 22, 2022
Liver Steatosis Trial (Transparietal ultrasound (US)-based shear wave elastography (SWE), Vibration-controlled transient
Not yet recruiting
- Liver Steatosis
- Transparietal ultrasound (US)-based shear wave elastography (SWE)
- +2 more
- (no location specified)
Oct 21, 2023
Hepatocellular Carcinoma Trial in Brussels (Radioembolization using Holmium-166)
Active, not recruiting
- Hepatocellular Carcinoma
- Radioembolization using Holmium-166
-
Brussels, Anderlecht, BelgiumHôpital Universitaire Erasme, ULB
Dec 7, 2022
Epidemiology: Oxidative Stress and Early Atherosclerosis
Completed
- Cardiovascular Diseases
- +3 more
- (no location specified)
Feb 9, 2022
Hepatocellular Carcinoma Trial in Munich, Würzburg (durvalumab, tremelimumab, bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- durvalumab, tremelimumab, bevacizumab
-
Munich, Germany
- +2 more
May 3, 2023
Whether Osteocrin Levels Are Associated With Glycemic Control, Vascular Disorders in Diabetic Patients Trial in Assiut
Recruiting
- Whether Osteocrin Levels Are Associated With Glycemic Control, Vascular Disorders in Diabetic Patients
- osteocrin
-
Assiut, Egyptwalaa soliman Hussien
Jan 31, 2023
Algorithm of Referable Diabetic Retinopathy From Fundus Images
Not yet recruiting
- Diabetic Retinopathy
- Color fundus photography
- +2 more
- (no location specified)
Jul 20, 2022
Learn More About Chronic Kidney Disease in Canadian Type 2
Completed
- Chronic Kidney Disease in Type 2 Diabetes
- The physician's prescription in routine clinical practice
-
A Database, CanadaA Database
Sep 28, 2021
Myocardial Fibrosis Associated With Monocyte Phenotype in End
Withdrawn
- Myocardial Fibrosis
- +4 more
- Cardiac MRI 1 - With Gadolinium Contrast
- +4 more
-
London, United KingdomImperial College Healthcare NHS Trust
Sep 30, 2021